Literature DB >> 30166364

Educational Disabilities Among Children Born With Neonatal Abstinence Syndrome.

Mary-Margaret A Fill1,2,3, Angela M Miller2, Rachel H Wilkinson4, Michael D Warren2, John R Dunn2,3, William Schaffner3, Timothy F Jones2,3.   

Abstract

BACKGROUND: Neonatal abstinence syndrome (NAS) is a postnatal drug withdrawal syndrome that can occur after intrauterine opioid exposure. Adverse neurobehavioral outcomes have been documented in infants with NAS; however, educational outcomes have not been thoroughly examined. We analyzed Tennessee data to understand the need for special educational services among infants who are born with NAS.
METHODS: By using Tennessee Medicaid and birth certificate data, infants who were born in Tennessee between 2008 and 2011 with a history of NAS were matched (1:3) to infants who were born during the same period without a history of NAS. Groups were matched on the basis of sex, race and/or ethnicity, age, birth region of residence, and Medicaid enrollment status. Data were linked to Tennessee Department of Education special education data during early childhood (3-8 years of age). Conditional multivariable logistic regression was used to assess associations between NAS and selected special education outcomes.
RESULTS: A total of 1815 children with a history of NAS and 5441 children without NAS were assessed. Children with NAS were significantly more likely to be referred for a disability evaluation (351 of 1815 [19.3%] vs 745 of 5441 [13.7%]; P < .0001), to meet criteria for a disability (284 of 1815 [15.6%] vs 634 of 5441 [11.7%]; P < .0001), and to require classroom therapies or services (278 of 1815 [15.3%] vs 620 of 5441 [11.4%]; P < .0001). These findings were sustained in a multivariable analysis, with multiple models controlling for maternal tobacco use, maternal education status, birth weight, gestational age, and/or NICU admission.
CONCLUSIONS: Results of this novel analysis linking health and education data revealed that children with a history of NAS were significantly more likely to have a subsequent educational disability.
Copyright © 2018 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2018        PMID: 30166364      PMCID: PMC6947655          DOI: 10.1542/peds.2018-0562

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  30 in total

1.  Academic Failure in Secondary School: The Inter-Related Role of Health Problems and Educational Context.

Authors:  Belinda L Needham; Robert Crosnoe; Chandra Muller
Journal:  Soc Probl       Date:  2004

Review 2.  Prenatal exposure to methadone and buprenorphine: a review of the potential effects on cognitive development.

Authors:  Carolien Konijnenberg; Annika Melinder
Journal:  Child Neuropsychol       Date:  2011-06-24       Impact factor: 2.500

3.  Effects of early intervention on intellectual and academic achievement: a follow-up study of children from low-income families.

Authors:  F A Campbell; C T Ramey
Journal:  Child Dev       Date:  1994-04

4.  CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  MMWR Recomm Rep       Date:  2016-03-18

5.  Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.

Authors:  Stephen W Patrick; Robert E Schumacher; Brian D Benneyworth; Elizabeth E Krans; Jennifer M McAllister; Matthew M Davis
Journal:  JAMA       Date:  2012-04-30       Impact factor: 56.272

6.  Adult outcomes as a function of an early childhood educational program: an Abecedarian Project follow-up.

Authors:  Frances A Campbell; Elizabeth P Pungello; Margaret Burchinal; Kirsten Kainz; Yi Pan; Barbara H Wasik; Oscar A Barbarin; Joseph J Sparling; Craig T Ramey
Journal:  Dev Psychol       Date:  2012-01-16

7.  Adverse neurodevelopmental outcome of infants exposed to opiate in-utero.

Authors:  Rod W Hunt; Dimitra Tzioumi; Edith Collins; Heather E Jeffery
Journal:  Early Hum Dev       Date:  2007-08-28       Impact factor: 2.079

8.  Early intervention in low birth weight premature infants: results at 18 years of age for the Infant Health and Development Program.

Authors:  Marie C McCormick; Jeanne Brooks-Gunn; Stephen L Buka; Julie Goldman; Jennifer Yu; Mikhail Salganik; David T Scott; Forrest C Bennett; Libby L Kay; Judy C Bernbaum; Charles R Bauer; Camilia Martin; Elizabeth R Woods; Anne Martin; Patrick H Casey
Journal:  Pediatrics       Date:  2006-03       Impact factor: 7.124

9.  Prevalence of developmental delays and participation in early intervention services for young children.

Authors:  Steven A Rosenberg; Duan Zhang; Cordelia C Robinson
Journal:  Pediatrics       Date:  2008-05-26       Impact factor: 7.124

10.  Longitudinal cognitive development of children born to mothers with opioid and polysubstance use.

Authors:  Egil Nygaard; Vibeke Moe; Kari Slinning; Kristine B Walhovd
Journal:  Pediatr Res       Date:  2015-05-15       Impact factor: 3.756

View more
  16 in total

1.  Surveillance for Emerging Threats to Pregnant Women and Infants.

Authors:  Meghan T Frey; Dana Meaney-Delman; Virginia Bowen; Mahsa M Yazdy; Sharon M Watkins; Phoebe G Thorpe; Margaret A Honein
Journal:  J Womens Health (Larchmt)       Date:  2019-08       Impact factor: 2.681

2.  Early Intervention Referral and Enrollment Among Infants with Neonatal Abstinence Syndrome.

Authors:  Elizabeth Peacock-Chambers; JoAnna K Leyenaar; Sheila Foss; Emily Feinberg; Donna Wilson; Peter D Friedmann; Paul Visintainer; Rachana Singh
Journal:  J Dev Behav Pediatr       Date:  2019 Jul/Aug       Impact factor: 2.225

Review 3.  Public Health Surveillance of Prenatal Opioid Exposure in Mothers and Infants.

Authors:  Margaret A Honein; Coleen Boyle; Robert R Redfield
Journal:  Pediatrics       Date:  2019-01-17       Impact factor: 7.124

4.  Surveillance, Epidemiology, and Estimated Burden of Neonatal Abstinence Syndrome, Tennessee, 2013-2016.

Authors:  Julia Brennan; Caleb Wiedeman; John R Dunn; William Schaffner; Timothy F Jones
Journal:  Public Health Rep       Date:  2019-08-07       Impact factor: 2.792

5.  One-Year Neurodevelopmental Outcomes After Neonatal Opioid Withdrawal Syndrome: A Prospective Cohort Study.

Authors:  Kristen L Benninger; Celine Richard; Sara Conroy; Julia Newton; H Gerry Taylor; Alaisha Sayed; Lindsay Pietruszewski; Mary Ann Nelin; Nancy Batterson; Nathalie L Maitre
Journal:  Perspect ASHA Spec Interest Groups       Date:  2022-06-27

6.  Five-Year Outcomes Among Medicaid-Enrolled Children With In Utero Opioid Exposure.

Authors:  Marian P Jarlenski; Elizabeth E Krans; Joo Yeon Kim; Julie M Donohue; A Everette James; David Kelley; Bradley D Stein; Debra L Bogen
Journal:  Health Aff (Millwood)       Date:  2020-02       Impact factor: 6.301

7.  Engagement in Early Intervention Services Among Mothers in Recovery From Opioid Use Disorders.

Authors:  Elizabeth Peacock-Chambers; Emily Feinberg; Molly Senn-McNally; Maria Carolina Clark; Briana Jurkowski; Nancy E Suchman; Nancy Byatt; Peter D Friedmann
Journal:  Pediatrics       Date:  2020-02       Impact factor: 7.124

8.  Opioid prescription claims among women aged 15-44 years-United States, 2013-2017.

Authors:  April D Summers; Elizabeth C Ailes; Michele K Bohm; Emmy L Tran; Cheryl S Broussard; Meghan T Frey; Suzanne M Gilboa; Jean Y Ko; Jennifer N Lind; Margaret A Honein
Journal:  J Opioid Manag       Date:  2021 Mar-Apr

9.  Evaluating Definitions for Neonatal Abstinence Syndrome.

Authors:  Kathleen M Doherty; Theresa A Scott; Anna Morad; Travis Crook; Elizabeth McNeer; Kim S Lovell; James C Gay; Stephen W Patrick
Journal:  Pediatrics       Date:  2020-12-02       Impact factor: 7.124

Review 10.  Prenatal Opioid Exposure: Neurodevelopmental Consequences and Future Research Priorities.

Authors:  Elisabeth Conradt; Tess Flannery; Judy L Aschner; Robert D Annett; Lisa A Croen; Cristiane S Duarte; Alexander M Friedman; Constance Guille; Monique M Hedderson; Julie A Hofheimer; Miranda R Jones; Christine Ladd-Acosta; Monica McGrath; Angela Moreland; Jenae M Neiderhiser; Ruby H N Nguyen; Jonathan Posner; Judith L Ross; David A Savitz; Steven J Ondersma; Barry M Lester
Journal:  Pediatrics       Date:  2019-09       Impact factor: 9.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.